AML and High Risk MDS
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) (NCT02078609) | Novartis Pharmaceuticals | 2014-03-20 |
Track AML and High Risk MDS automatically
Every clearance here is in the API, with alerts when new ones post.